ClinVar Miner

Submissions for variant NM_007327.4(GRIN1):c.1012G>A (p.Val338Met) (rs140672142)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000688402 SCV000816012 likely benign Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 2020-10-08 criteria provided, single submitter clinical testing
Ambry Genetics RCV000720532 SCV000851410 uncertain significance History of neurodevelopmental disorder 2016-12-28 criteria provided, single submitter clinical testing The p.V338M variant (also known as c.1012G>A), located in coding exon 7 of the GRIN1 gene, results from a G to A substitution at nucleotide position 1012. The valine at codon 338 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Mayo Clinic Laboratories, Mayo Clinic RCV001508287 SCV001714341 uncertain significance not provided 2019-10-28 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.